Removal of calcium by either citrate, oxalate, or ethylenediaminetetraacetate inhibited coagulation of blood at an early stage and prevented the release of ,8-lysin from platelets. In contrast, heparin caused platelet agglutination and stimulated fB-lysin release in vitro and in vivo. This release was calcium dependent and may have been due to a calcium-dependent reaction in the blood coagulation sequence. Thrombin which by-passed the early calcium-dependent stages of coagulation directly stimulated the release of,-lysin from platelets. However, thrombin alone or in combination with other plasma factors was not as effective in releasing,-lysin as the regular coagulation process. Thrombin's platelet degranulating activity correlated with its,-lysin releasing activity. In contrast to thrombin, staphylococcal coagulase, which also by-passed the calcium-dependent stages of coagulation, coagulated citrated blood without releasing ,B-lysin. The release of,-lysin has been observed previously in the absence of blood coagulation, but this is the first observation of coagulation without ,B-lysin release. It is clear that 8-lysin is released from platelets during coagulation by the direct action of thrombin and that it may be released in an earlier calcium-dependent reaction.
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In 1901 Gengou (6) reported that, in comparison with serum prepared from whole blood, plasma serum exhibited only low levels of bactericidal activity for gram-positive bacteria (plasma serum was prepared from coagulated plasma which had been depleted of all cells and platelets prior to clot formation). Later, the substance responsible for this activity in serum was named ,B-lysin. In 1958, Donaldson and Marcus (3) confirmed Gengou's observation in experiments comparing ,B-lysin activities in plasma and serum. They demonstrated that anticoagulants were not directly responsible for the lack of plasma bactericidal activity, because addition of anticoagulants to serum did not alter its bactericidal effect. In 1960, Hirsch (9) demonstrated that ,8-lysin activity could be obtained in plasma serum if platelets were restored to the plasma prior to clot formation, thus establishing that blood platelets were the source of ,B-lysin in blood serum. This was later confirmed by the observation (4) that antisera prepared against purified ,8-lysin completely neutralized this bactericidal activity in serum and platelet extracts. Furthermore, all of these data show that blood coagulation is essential in the liberation of,-lysin from platelets. However, no attempt has been made to determine which reactions in the coagulation mechanism are responsible for releasing the intracellular ,8-lysin. The objective of the present study was to determine the ,B-lysin-releasing reactions in the blood coagulation sequence.
MATERIALS AND METHODS Animals. New Zealand white rabbits weighing 5 to 6 lb were obtained from a local supplier. They were individually caged, fed rabbit pellets, and given water ad libitum.
,B-Lysin assay. ,-lysin was assayed as described by Donaldson et al. (2) . This procedure requires that a standard inoculum of Bacillus subtilis be added to various dilutions of a test sample. After incubation, pour plates were prepared, and the cell viability was determined for each dilution. The reciprocal of the highest dilution which was lethal for a minimum of 99% of the bacteria was the ,-lysin titer for the test sample.
,B-Lysin neutralization. The anti-,B-lysin plasma used in all neutralization tests was prepared in guinea pigs by injecting purified rabbit ,-lysin as previously reported (4 (15) , and 8 to 32 coagulase units/ml were used to coagulate PRP.
Thrombin and heparin. Bovine thrombin obtained from K and K Laboratories, Hollywood, Calif., was used in a concentration of 0.66 mg/ml of blood or PRP. The heparin used was an aqueous preparation obtained from Riker Laboratories, Northridge, Calif.
RESULTS
Anticoagulants and ,B-lysin release. To assess the,-lysin-releasing capacity of early reactions in the blood coagulation sequence, the release of,-lysin was studied in the presence of anticoagulants which block coagulation prior to the generation of thrombin (Table 1) . Blood samples were collected from rabbits by cardiac puncture in syringes containing the indicated anticoagulants. The blood samples were incubated for 1 h at 37 C to allow ample time for the coagulation process to proceed to the blocked step. The samples were then centrifuged, and the supernatant fluids were assayed for fl-lysin.
In the absence of anti-coagulant, the,-lysin titers ranged from 32 to 128 U/ml. In the presence of sodium citrate, potassium oxalate, or ethylenediaminetetraacetate, the fB-lysin titers were reduced to 1 or 2 U/ml. This result was anticipated, because all of these agents chelate calcium ions and block the coagulation mechanism at an early step. Heparin, however, only partially blocked the ,B-lysin release. Sixteen of the 64 ,8-lysin units present in serum were released in the presence of heparin. Treatment with anti-f,-lysin plasma neutralized the bactericidal activity in all cases, indicating that the lethal agent was in fact ,B-lysin.
In an effort to understand the release of ,B-lysin that occurred in the presence of heparin, a study comparing the effect of various concentrations of heparin on whole blood was carried out. It was anticipated that the higher concentrations of heparin would be most effective in inhibiting the release of fB-lysin, the rate and quantity of fB-lysin release increased with heparin concentration (Fig. 1) . Either heparin stimulated an early ,8-lysin releasing step in the coagulation process or it activated a,-lysinreleasing mechanism which was independent of the coagulation process. However, an investigation of the divalent ion requirement of the h After dilution of the test sample with an equal volume of anti--lysin, 2 U/ml is the smallest amount of,-lysin that can be measured. In reality, the antibody has probably completely neutralized the bactericidal activity, because no killing of bacteria was evident in any tubes containing anti-,8-lysin. heparin-induced 6-lysin release revealed that the ion requirements were similar to ion requirements in early steps in the coagulation process ( Table 2 ). The addition of calcium to heparinized whole blood stimulated the release of additional ,8-lysin, whereas the removal of calcium by the addition of sodium citrate blocked the ,B-lysin-releasing mechanism. The ionic specificity of this reaction was indicated by the fact that calcium would remove the block, whereas magnesium would not.
A study of the effect of heparin on PRP was carried out to examine the effect of this ,-lysin release on the blood platelet. PRP was prepared with citrate, because it was not possible to obtain a preparation with high concentrations of platelets when heparin alone was used as the anticoagulant. Ten USP units of heparin per ml and 3.0 x 10-5 mol of calcium per ml were added to one portion of PRP prepared with citrate. The untreated PRP served as a control.
The concentrati'on of calcium used was sufficient to allow the PRP to clot in the absence of heparin. At various times after the calcium and heparin additions, samples were collected, and the extracellular,6-lysin level and platelet number were determined (Fig. 2) . The addition of calcium and heparin caused a rapid drop in platelet number and a corresponding increase in the ,B-lysin concentration. In contrast, the controls showed only a slight decrease in platelet number and a correspondingly small increase in ,B-lysin. At the conclusion of the experiment, an examination of the control platelets under a phase contrast microscope revealed that they were slightly rounded, but otherwise they appeared to be normal (Fig. 3A) . In contrast, nearly all treated platelets were found in aggregates like the one in Fig. 3B . This agglutination phenomenon accounts for the large decrease in platelet number, as measured by the Coulter counter (Fig. 2) . Individually, the agglutinated platelets looked rounded and deformed. These changes in morphology and the agglutination reaction were dependent on both calcium and heparin, because platelets (Fig. 4) in heparin alone were indistinguishable from the controls. The typical alterations in platelets after a 60-min treatment with heparin and calcium are seen in Fig. 4B . These platelets clumped very tightly together, membrane damage was evident, and most of the platelets appeared to be in the process of breaking up. In view of the release of heparin and ,8-lysin (14) during anaphylaxis, a study was initiated in the coagulation sequence, thrombin and tion of thrombin, which by-passed the early calstaphylococcal coagulase were added to ci-cium-dependent stages of coagulation, coagutrated blood (Table 3 ). The addition of calcium lated the blood and released ,B-lysin from the served as a positive control by activating the platelets. However, thrombin was only about normal blood coagulation mechanism which in one-fourth as effective as calcium in releasing turn released serum levels of s-lysin. The addi-,B-lysin. In contrast to the obvious release with 7 \~~~~~~~~~~_ 2 .a' RELEASE OF ,9-LYSIN FROM PLATELETS thrombin, the addition of staphylococcal coagulase, which also by-passed the calcium-dependent stages of blood coagulation, coagulated the citrated blood without releasing significantly more ,B-lysin than the untreated control. Coagulase was not directly neutralizing ,-lysin, because the addition of coagulase to serum did not inhibit bactericidal activity. It should be emphasized that in this experiment the coagulase preparation cannot be contaminated with staphylococcal a-hemolysin, because a-hemolysin will lyse platelets and release fB-lysin. The inability of staphylococcal coagulase to release f3-lysin may be related to the clot retraction reaction. Whenever the fibrinogen-to-fibrin reaction was driven by thrombin, good clot retraction was observed. Staphylococcal coagulase caused coagulation with little or no clot retraction.
To determine whether the thrombinmediated ,B-lysin release was due to the direct action of thrombin or to a subsequent reaction, thrombin was added to a platelet preparation in the absence of the plasma proteins (Table 4) . In this study, PRP was separated from citrated whole blood, and the platelets were sedimented at 900 x g for 5 min. The platelet buttons were then washed twice in PSS to remove any residual plasma proteins and resuspended in either PSS or plasma. The addition of thrombin to platelets in PSS alone resulted in a fourfold increase in extracellular ,8-lysin, indicating that thrombin will act directly on the platelet to release :-lysin. However, the addition of thrombin to platelets in plasma resulted in a 16-fold increase in extracellular s-lysin, indicating that a reaction subsequent to thrombin activation must play a role in B-lysin release or that a plasma factor must normally assist thrombin in releasing ,-lysin from platelets. Examination of these platelets under an electron microscope revealed that the addition of thrombin induced extensive platelet degranulation. Figure 5 shows the typical alterations observed in thrombintreated rabbit platelets. The 
DISCUSSION
The intrinsic system of blood coagulation is presented in Fig. 6 (1, 10) . The first two reactions in this system (numbers XII and XI) could not have been responsible for ,B-lysin release, because they are independent of calcium and proceed in the presence of the chelating anticoagulants which block,-lysin release. Likewise, the fibrinogen-to-fibrin reaction may be eliminated as a ,8-lysin-releasing reaction, because staphylococcal coagulase can drive this reaction in the presence of platelets and not release ,8-lysin. Heparin has some inhibitory activity on several steps in the coagulation process (7); however, its major activity is to prevent the conversion of prothrombin to thrombin (11, 13) . Thus in the presence of this anticoagulant, three additional reactions, all of which require calcium, could occur, and one of these reactions could be the basis for the heparin-induced ,-lysin release. It is possible that :-lysin is released with platelet factors 1 and 3 which are active in these reactions.
Recently Eika (5) reported that heparin increased platelet adhesiveness by causing platelets to release adenosine diphosphate (ADP) which aggregated the platelets. However, when we aggregated platelets in PRP with ADP, we were never able to demonstrate a release of ,B-lysin, indicating that aggregation and,-lysin release are independent phenomena. Conse- Although thrombin alone is capable of releasing ,B-lysin from platelets, its releasing activity is enhanced by other plasma factors. However, even in the presence of these plasma factors, normal coagulation is more effective than thrombin in releasingf,-lysin. This also supports the hypothesis that at least two reactions are responsible for the release of fl-lysin during normal blood coagulation. The first of these reactions would be calcium dependent, and the second would be the result of thrombin activation.
The finding that staphylococcal coagulase does not release ,-lysin is consistent with the recent reports that coagulase does not affect platelets and that its coagulating activity is not mediated by thrombin activation (12) . ,B-Lysin release from platelets into plasma has been previously observed in the absence of blood coagulation (14) , but this is the first observation of blood coagulation without a ,l-lysin release.
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